Hologic (HOLX) Competitors $58.02 -0.27 (-0.46%) Closing price 04/25/2025 04:00 PM EasternExtended Trading$58.52 +0.50 (+0.87%) As of 04/25/2025 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock HOLX vs. EW, IDXX, RMD, DXCM, STE, PODD, BAX, GMED, MASI, and TFXShould you be buying Hologic stock or one of its competitors? The main competitors of Hologic include Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), STERIS (STE), Insulet (PODD), Baxter International (BAX), Globus Medical (GMED), Masimo (MASI), and Teleflex (TFX). These companies are all part of the "health care equipment" industry. Hologic vs. Edwards Lifesciences IDEXX Laboratories ResMed DexCom STERIS Insulet Baxter International Globus Medical Masimo Teleflex Edwards Lifesciences (NYSE:EW) and Hologic (NASDAQ:HOLX) are both large-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, community ranking, profitability, institutional ownership, valuation, risk, dividends and media sentiment. Is EW or HOLX more profitable? Edwards Lifesciences has a net margin of 72.93% compared to Hologic's net margin of 18.42%. Hologic's return on equity of 19.72% beat Edwards Lifesciences' return on equity.Company Net Margins Return on Equity Return on Assets Edwards Lifesciences72.93% 19.40% 14.37% Hologic 18.42%19.72%10.94% Does the MarketBeat Community believe in EW or HOLX? Edwards Lifesciences received 457 more outperform votes than Hologic when rated by MarketBeat users. Likewise, 70.76% of users gave Edwards Lifesciences an outperform vote while only 69.32% of users gave Hologic an outperform vote. CompanyUnderperformOutperformEdwards LifesciencesOutperform Votes133870.76% Underperform Votes55329.24% HologicOutperform Votes88169.32% Underperform Votes39030.68% Which has more risk and volatility, EW or HOLX? Edwards Lifesciences has a beta of 1.15, indicating that its stock price is 15% more volatile than the S&P 500. Comparatively, Hologic has a beta of 0.82, indicating that its stock price is 18% less volatile than the S&P 500. Do insiders & institutionals have more ownership in EW or HOLX? 79.5% of Edwards Lifesciences shares are owned by institutional investors. Comparatively, 94.7% of Hologic shares are owned by institutional investors. 0.3% of Edwards Lifesciences shares are owned by company insiders. Comparatively, 1.9% of Hologic shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Do analysts rate EW or HOLX? Edwards Lifesciences presently has a consensus target price of $79.45, suggesting a potential upside of 4.46%. Hologic has a consensus target price of $84.62, suggesting a potential upside of 45.84%. Given Hologic's higher possible upside, analysts plainly believe Hologic is more favorable than Edwards Lifesciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Edwards Lifesciences 1 Sell rating(s) 12 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.42Hologic 0 Sell rating(s) 11 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.41 Which has better earnings and valuation, EW or HOLX? Edwards Lifesciences has higher revenue and earnings than Hologic. Edwards Lifesciences is trading at a lower price-to-earnings ratio than Hologic, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEdwards Lifesciences$5.44B8.22$4.17B$6.9710.91Hologic$4.04B3.22$789.50M$3.1718.30 Does the media favor EW or HOLX? In the previous week, Edwards Lifesciences had 39 more articles in the media than Hologic. MarketBeat recorded 62 mentions for Edwards Lifesciences and 23 mentions for Hologic. Edwards Lifesciences' average media sentiment score of 1.14 beat Hologic's score of 0.86 indicating that Edwards Lifesciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Edwards Lifesciences 34 Very Positive mention(s) 2 Positive mention(s) 12 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Hologic 12 Very Positive mention(s) 1 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive SummaryEdwards Lifesciences beats Hologic on 13 of the 19 factors compared between the two stocks. Get Hologic News Delivered to You Automatically Sign up to receive the latest news and ratings for HOLX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HOLX vs. The Competition Export to ExcelMetricHologicX IndustryMedical SectorNASDAQ ExchangeMarket Cap$13.66B$11.57B$5.46B$7.81BDividend YieldN/A1.98%5.43%4.26%P/E Ratio18.3017.0522.4318.48Price / Sales3.228.04391.42101.49Price / Cash11.6911.9038.1834.62Price / Book2.732.036.684.19Net Income$789.50M$344.53M$3.22B$248.18M7 Day Performance0.80%6.70%6.25%6.54%1 Month Performance-6.90%-5.96%-2.70%-1.97%1 Year Performance-23.64%13.30%16.86%4.72% Hologic Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HOLXHologic4.822 of 5 stars$58.02-0.5%$84.62+45.8%-23.6%$13.02B$4.04B18.306,940Upcoming EarningsPositive NewsEWEdwards Lifesciences4.4824 of 5 stars$68.93-3.6%$78.55+14.0%-12.0%$40.52B$5.44B9.8917,300Earnings ReportAnalyst ForecastShort Interest ↓Analyst RevisionPositive NewsIDXXIDEXX Laboratories4.4064 of 5 stars$404.06-1.8%$523.75+29.6%-12.4%$33.35B$3.90B37.8710,800Upcoming EarningsPositive NewsRMDResMed3.89 of 5 stars$210.03-1.4%$250.08+19.1%+8.1%$30.85B$4.93B24.808,160Earnings ReportDividend AnnouncementAnalyst RevisionDXCMDexCom4.9476 of 5 stars$65.50-4.5%$99.00+51.1%-42.4%$25.68B$4.03B45.807,600Upcoming EarningsPositive NewsSTESTERIS4.4763 of 5 stars$217.52-2.1%$258.75+19.0%+10.3%$21.37B$5.40B46.1816,000Short Interest ↑Positive NewsPODDInsulet4.6199 of 5 stars$238.35-3.4%$292.06+22.5%+56.9%$16.74B$2.07B41.172,600Positive NewsBAXBaxter International4.672 of 5 stars$28.57-1.1%$38.56+35.0%-24.7%$14.65B$10.64B-22.3260,000Upcoming EarningsGMEDGlobus Medical4.7837 of 5 stars$68.96-2.9%$96.91+40.5%+44.1%$9.48B$2.52B91.952,600Short Interest ↑MASIMasimo3.8005 of 5 stars$148.61-2.3%$194.80+31.1%+20.3%$8.03B$2.09B102.496,200Positive NewsTFXTeleflex4.8122 of 5 stars$128.18-1.0%$169.63+32.3%-34.7%$5.94B$3.05B25.4815,500Upcoming EarningsShort Interest ↓Positive News Related Companies and Tools Related Companies Edwards Lifesciences Alternatives IDEXX Laboratories Alternatives ResMed Alternatives DexCom Alternatives STERIS Alternatives Insulet Alternatives Baxter International Alternatives Globus Medical Alternatives Masimo Alternatives Teleflex Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HOLX) was last updated on 4/28/2025 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hologic, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hologic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
